1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

A commercial nutraceutical mix Metabolic Cell-Support (MC-S) inhibits proliferation of cancer cell

A commercial nutraceutical mix Metabolic Cell-Support (MC-S) inhibits proliferation of cancer cell

  1. Calliope
    Australian Journal of Medical Herbalism, Summer, 2009, Vol.21(2), p.39(5)

    Clark, D. A. ; Adams, M. C.

    Abstract
    Description: Metabolic Cell Support (MC-S), now manufactured by Clinical Health Pty Ltd, is an over the counter immune supplement developed in Australia. Rather than using individual bioactive chemicals, a combined highly standardised multipolysaccharide enriched mix of medicinal mushrooms, the herb Astragalus mebranasis and ascorbic acid was formulated so as not to exclude important components of the original herb that may play a role in clinical outcomes. To examine the potential effect of MC-S on cancer, an in vitro proliferation study using diverse types of cancer cell lines was undertaken. Breast (MCF-7), prostate (DU145), melanoma (MM200) and colon (HT29) cancer cells were cultured under controlled standard conditions in the presence of MC-S at varying doses. After 48 and 72 hours of incubation, proliferation was measured using CellTiter 96 AQueous Non-Radioactive Cell proliferation assay kit. Results MC-S significantly inhibited the growth of breast, prostate, melanoma and bowl cancer cells, over a broad range of doses. Conclusions MC-S in this study was shown to inhibit cancer cell growth. This result, along with previous studies identifying immune stimulation properties, suggests that MC-S may offer additional benefit to standard cancer therapies.